First MR Linac Radiotherapy System Installed in UK
By Andrew Deutsch Posted on 30 Nov 2016 |
Image: The MR-LINAC aims to provide soft tissue imaging during radiation therapy while adapting treatment delivery in real-time for precise cancer treatments (Photo courtesy of Elekta).
A revolutionary new radiotherapy system intended for specialized cancer care has been installed in London, in the UK.
The MR linac system uses Magnetic Resonance Imaging (MRI) and X-Rays simultaneously allowing oncologists to adjust radiotherapy treatments in real time and deliver more accurate and effective radiation doses.
The MR Linac system was developed by Elekta (Stockholm, Sweden), and was installed at the Institute of Cancer Research (London, UK) and the Royal Marsden NHS Foundation Trust. The first patients are expected to be treated there as part of clinical studies in the second half of 2017. The technology is expected increase the effectiveness of radiotherapy treatment while reducing side effects, especially for cancers that move during radiotherapy, or patients that need to change position between imaging and treatment.
Professor Uwe Oelfke, from the Institute of Cancer Research, and The Royal Marsden NHS Foundation Trust, said, “Combining the excellent soft-tissue contrast of MRI scanning with precision radiotherapy in a single treatment technology has been one of the major challenges of modern radiotherapy research. The launch of our new system is an important step towards finally making this state-of-the-art treatment available for patients in the UK – with our first clinical trials due to begin in about a year’s time. By doing accurate patient imaging at the same time as delivery of radiotherapy – rather than as separate steps – we aim to significantly improve treatment for patients with hard-to-treat cancers including lung cancer.”
Related Links:
Elekta
Institute of Cancer Research
The MR linac system uses Magnetic Resonance Imaging (MRI) and X-Rays simultaneously allowing oncologists to adjust radiotherapy treatments in real time and deliver more accurate and effective radiation doses.
The MR Linac system was developed by Elekta (Stockholm, Sweden), and was installed at the Institute of Cancer Research (London, UK) and the Royal Marsden NHS Foundation Trust. The first patients are expected to be treated there as part of clinical studies in the second half of 2017. The technology is expected increase the effectiveness of radiotherapy treatment while reducing side effects, especially for cancers that move during radiotherapy, or patients that need to change position between imaging and treatment.
Professor Uwe Oelfke, from the Institute of Cancer Research, and The Royal Marsden NHS Foundation Trust, said, “Combining the excellent soft-tissue contrast of MRI scanning with precision radiotherapy in a single treatment technology has been one of the major challenges of modern radiotherapy research. The launch of our new system is an important step towards finally making this state-of-the-art treatment available for patients in the UK – with our first clinical trials due to begin in about a year’s time. By doing accurate patient imaging at the same time as delivery of radiotherapy – rather than as separate steps – we aim to significantly improve treatment for patients with hard-to-treat cancers including lung cancer.”
Related Links:
Elekta
Institute of Cancer Research
Latest MRI News
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer
- AI-Based MRI Tool Outperforms Current Brain Tumor Diagnosis Methods
- DW-MRI Lights up Small Ovarian Lesions like Light Bulbs